Nutrasource Pharmaceutical and Nutraceutical Services

Nutrasource Pharmaceutical and Nutraceutical Services specializes in providing comprehensive support for the commercialization of health and wellness products through clinical trial management, regulatory consulting, and product certification. Nutrasource Pharmaceutical and Nutraceutical Services operates in the nutraceutical and pharmaceutical sectors, offering services designed to help clients bring health products to market. Founded in 2002, the company is headquartered in Guelph, Canada, and was established by William Rowe, who has a background in the industry. The company raised CAD 2 million in venture funding from BDC Capital on June 3, 2019, marking a key milestone in its funding history.

Nutrasource has completed a total of one deal to date, with all funding efforts directed towards enhancing its service offerings. Nutrasource is a leading provider of specialized services in the nutraceutical and pharmaceutical sectors, offering a comprehensive suite of solutions designed to support clients in the commercialization of health and wellness products. Their core offerings include clinical trial management, regulatory consulting, and product certification programs, which aim to streamline the pathway to market for various health-related products. Nutrasource’s certifications, such as NutraStrong™, IFOS™, and IGEN™, help ensure the quality and efficacy of dietary supplements, natural health products, and pharmaceuticals.

The company serves a diverse clientele, including manufacturers of pet food, dietary supplements, pharmaceuticals, and food and beverage products, catering to markets across North America, Canada, and emerging international markets. The end users of their services range from health and wellness consumers to industry professionals seeking validated product claims and regulatory compliance. Revenue generation for Nutrasource primarily occurs through contractual agreements with clients seeking to utilize their extensive range of services. The company engages in business-to-business transactions, providing support through clinical trial services, regulatory strategy consultation, analytical testing, and product certification.

Clients may enter into partnerships or agreements that involve fees based on the scope of services rendered, including ongoing support for product development and certification processes. Flagship offerings such as their certification programs enhance the firm’s positioning in the market, contributing to sustained revenue streams. Through these structured transactions, Nutrasource effectively addresses the needs of its clients while facilitating the launch of compliant and high-quality health products. In June 2019, Nutrasource Pharmaceutical and Nutraceutical Services raised CAD 2 million in venture funding from new investor BDC Capital Inc.

This funding is expected to support the company’s strategy for future growth, particularly in developing new products and enhancing service offerings. Specific plans include expanding into new markets, with a focus on international regions that align with the company’s service capabilities. Nutrasource aims to leverage recent funding to accelerate product development timelines and enhance marketing efforts as it seeks to broaden its geographic reach.